311 related articles for article (PubMed ID: 1512230)
1. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.
Theuer CP; FitzGerald D; Pastan I
J Biol Chem; 1992 Aug; 267(24):16872-7. PubMed ID: 1512230
[TBL] [Abstract][Full Text] [Related]
2. Analysis of sequences required for the cytotoxic action of a chimeric toxin composed of Pseudomonas exotoxin and transforming growth factor alpha.
Kihara A; Pastan I
Bioconjug Chem; 1994; 5(6):532-8. PubMed ID: 7873657
[TBL] [Abstract][Full Text] [Related]
3. Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.
Mesri EA; Kreitman RJ; Fu YM; Epstein SE; Pastan I
J Biol Chem; 1993 Mar; 268(7):4853-62. PubMed ID: 8444864
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin.
Siegall CB; Xu YH; Chaudhary VK; Adhya S; Fitzgerald D; Pastan I
FASEB J; 1989 Dec; 3(14):2647-52. PubMed ID: 2556314
[TBL] [Abstract][Full Text] [Related]
5. Analysis of sequences in domain II of Pseudomonas exotoxin A which mediate translocation.
Siegall CB; Ogata M; Pastan I; FitzGerald DJ
Biochemistry; 1991 Jul; 30(29):7154-9. PubMed ID: 1906738
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin.
Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
J Biol Chem; 1989 Aug; 264(24):14256-61. PubMed ID: 2503515
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas exotoxin A-epidermal growth factor (EGF) mutant chimeric protein as an indicator for identifying amino acid residues important in EGF-receptor interaction.
Shiah HS; Chen TY; Chang CM; Chow JT; Kung HJ; Hwang J
J Biol Chem; 1992 Nov; 267(33):24034-40. PubMed ID: 1429738
[TBL] [Abstract][Full Text] [Related]
8. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.
Arora N; Klimpel KR; Singh Y; Leppla SH
J Biol Chem; 1992 Aug; 267(22):15542-8. PubMed ID: 1639793
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity.
Chaudhary VK; Jinno Y; FitzGerald D; Pastan I
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):308-12. PubMed ID: 2104981
[TBL] [Abstract][Full Text] [Related]
10. A target-specific chimeric toxin composed of epidermal growth factor and Pseudomonas exotoxin A with a deletion in its toxin-binding domain.
Liao CW; Hseu TH; Hwang J
Appl Microbiol Biotechnol; 1995 Jul; 43(3):498-507. PubMed ID: 7632400
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of a transforming growth factor-alpha--Pseudomonas exotoxin fusion protein in vitro and in vivo.
Heimbrook DC; Stirdivant SM; Ahern JD; Balishin NL; Patrick DR; Edwards GM; Defeo-Jones D; FitzGerald DJ; Pastan I; Oliff A
J Ind Microbiol; 1991 Apr; 7(3):203-7. PubMed ID: 1367127
[TBL] [Abstract][Full Text] [Related]
12. A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer.
Theuer CP; FitzGerald DJ; Pastan I
J Urol; 1993 Jun; 149(6):1626-32. PubMed ID: 8501821
[TBL] [Abstract][Full Text] [Related]
13. Small chimeric toxins containing only transforming growth factor alpha and domain III of Pseudomonas exotoxin with good antitumor activity in mice.
Kihara A; Pastan I
Cancer Res; 1994 Oct; 54(19):5154-9. PubMed ID: 7923133
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effect of a fusion protein from transforming growth factor alpha and Pseudomonas exotoxin on rat and human bladder carcinoma cells in vitro.
Kameyama S; Kawamata H; Pastan I; Oyasu R
J Cancer Res Clin Oncol; 1994; 120(9):507-12. PubMed ID: 8045915
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal region of the 37-kDa translocated fragment of Pseudomonas exotoxin A aborts translocation by promoting its own export after microsomal membrane insertion.
Theuer CP; Buchner J; FitzGerald D; Pastan I
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7774-8. PubMed ID: 8356083
[TBL] [Abstract][Full Text] [Related]
16. An EGF-pseudomonas exotoxin A recombinant protein with a deletion in toxin binding domain specifically kills EGF receptor bearing cells.
Lee CH; Lee EC; Tsai ST; Kung HJ; Liu YC; Hwang J
Protein Eng; 1993 Jun; 6(4):433-40. PubMed ID: 8332601
[TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins.
Jeschke M; Wels W; Dengler W; Imber R; Stöcklin E; Groner B
Int J Cancer; 1995 Mar; 60(5):730-9. PubMed ID: 7860149
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol.
Ogata M; Fryling CM; Pastan I; FitzGerald DJ
J Biol Chem; 1992 Dec; 267(35):25396-401. PubMed ID: 1460035
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor binding is affected by structural determinants in the toxin domain of transforming growth factor-alpha-Pseudomonas exotoxin fusion proteins.
Edwards GM; DeFeo-Jones D; Tai JY; Vuocolo GA; Patrick DR; Heimbrook DC; Oliff A
Mol Cell Biol; 1989 Jul; 9(7):2860-7. PubMed ID: 2779550
[TBL] [Abstract][Full Text] [Related]
20. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL.
Seetharam S; Chaudhary VK; FitzGerald D; Pastan I
J Biol Chem; 1991 Sep; 266(26):17376-81. PubMed ID: 1910044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
